相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice
Vishnu N. Thakare et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Sodium Butyrate Controls Cardiac Hypertrophy in Experimental Models of Rats
Bhoomika M. Patel
CARDIOVASCULAR TOXICOLOGY (2018)
Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease
Jong Kil Lee et al.
MOLECULES (2017)
Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response
Vishnu N. Thakare et al.
PHYSIOLOGY & BEHAVIOR (2017)
Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: Modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus
Vishnu N. Thakare et al.
PHARMACOLOGICAL REPORTS (2016)
Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart
Eva Gabrielova et al.
PLOS ONE (2015)
Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction
Nihar Rayabarapu et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2014)
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril
Bhoomika M. Patel et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2014)
Novel quinazoline-urea analogues as modulators for Aβ-induced mitochondrial dysfunction: Design, synthesis, and molecular docking study
Ahmed Elkamhawy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus
Bhoomika M. Patel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Silymarin and its constituents in cardiac preconditioning
A. Zholobenko et al.
FITOTERAPIA (2014)
A p38 Substrate-Specific MK2-EGFP Translocation Assay for Identification and Validation of New p38 Inhibitors in Living Cells: A Comprising Alternative for Acquisition of Cellular p38 Inhibition Data
Roman Anton et al.
PLOS ONE (2014)
Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy
Bhoomika M. Patel et al.
PHARMACOLOGICAL REPORTS (2014)
Immunosuppressive Effect of Silymarin on Mitogen-Activated Protein Kinase Signalling Pathway: the Impact on T Cell Proliferation and Cytokine Production
Marjan Gharagozloo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action
Anupom Borah et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Choice of anti-hypertensive agents in diabetic subjects
Bhoomika M. Patel et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Effect of Spironolactone on Cardiovascular Complications Associated with Type-2 Diabetes in Rats
B. M. Patel et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
Therapeutic implications of small interfering RNA in cardiovascular diseases
Suchi Raghunathan et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2013)
Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfuntion
B. R. Goyal et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2013)
Mitochondria in cardiac hypertrophy and heart failure
Mariana G. Rosca et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy
Bhoomika R. Goyal et al.
ACTA CARDIOLOGICA (2012)
Role of p38 inhibition in cardiac ischemia/reperfusion injury
Sarawut Kumphune et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases
Bhoomika M. Patel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
被撤回的出版物: Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats with CCl4-Induced Liver Cirrhosis (Retracted article. See art no 5276749, 2017)
Ping-Chun Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations
B. M. Patel et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2012)
Interrelationship Between Cardiac Hypertrophy, Heart Failure, and Chronic Kidney Disease Endoplasmic Reticulum Stress As a Mediator of Pathogenesis
Jeffrey G. Dickhout et al.
CIRCULATION RESEARCH (2011)
Mitochondrial Oxidative Stress Mediates Angiotensin II-Induced Cardiac Hypertrophy and Gαq Overexpression-Induced Heart Failure
Dao-Fu Dai et al.
CIRCULATION RESEARCH (2011)
Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats
Bhoomika R. Goyal et al.
PHARMACOLOGICAL REPORTS (2011)
Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications
Richard E. Katholi et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2011)
Mitochondria in the diabetic heart
Heiko Bugger et al.
CARDIOVASCULAR RESEARCH (2010)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the US Preventive Services Task Force
David I. Buckley et al.
ANNALS OF INTERNAL MEDICINE (2009)
Investigation Into the Cardiac Effects of Spironolactone in the Experimental Model of Type 1 Diabetes
Bhoomika R. Goyal et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats
Bhoomika R. Goyal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: A hospital-based, prospective study in Greek patients
Vasileios Peppes et al.
CLINICAL INTERVENTIONS IN AGING (2008)
Burn injury decreases myocardial Na-K-ATPase activity: Role of PKC inhibition
Jureta W. Horton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Advances in the use of milk thistle (Silybum marianum)
Janice Post-White et al.
INTEGRATIVE CANCER THERAPIES (2007)
Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent
Bei Zhou et al.
ACTA PHARMACOLOGICA SINICA (2007)
Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways
PN Chen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2005)
Silymarin augments human cervical cancer HeLa cell apoptosis via P38/JNK MAPK pathways in serum-free medium
Q Huang et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2005)
The MKK6-p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT
C Andrews et al.
CARDIOVASCULAR RESEARCH (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets
N Skottova et al.
PHARMACOLOGICAL RESEARCH (2003)
Aortic constriction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E
JH Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Cytoplasmic signaling pathways that regulate cardiac hypertrophy
JD Molkentin et al.
ANNUAL REVIEW OF PHYSIOLOGY (2001)
Role of oxidative stress in cardiovascular diseases
NS Dhalla et al.
JOURNAL OF HYPERTENSION (2000)
Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals
G Barja et al.
FASEB JOURNAL (2000)
分享论文
